shortagewatch

Home / Musculoskeletal system / Pamidronic Acid

ATC M05BA03 · Drugs for Treatment of Bone Diseases

Pamidronic Acid shortage

As of 31 Oct 2026, Pamidronic Acid has a reported shortage in 2 of the 5 countries we track (Germany, Belgium), covering 7 products.

Countries2/5
Products7packs or presentations
Short since11 Dec 202511 months ago
Earliest return31 Dec 2026company estimate
No return date0products
Main reasonManufacturing problem
Germany6 packs shortItalyNo reported shortageSpainNo reported shortageAustriaNo reported shortageBelgium1 pack short

Timeline

GermanyBelgium
20262027PAMIDRO-cell 3 mg/ml Konzentrat zur HerstellPAMIDRO-cell 3 mg/ml Konzentrat zur Herstellung einer InfusionslösungPAMIDRO-cell 3 mg/ml Konzentrat zur HerstellPAMIDRO-cell 3 mg/ml Konzentrat zur Herstellung einer InfusionslösungPAMIDRO-cell 3 mg/ml Konzentrat zur HerstellPAMIDRO-cell 3 mg/ml Konzentrat zur Herstellung einer InfusionslösungPAMIDRO-cell 3 mg/ml Konzentrat zur HerstellPAMIDRO-cell 3 mg/ml Konzentrat zur Herstellung einer InfusionslösungPAMIDRO-cell 3 mg/ml Konzentrat zur HerstellPAMIDRO-cell 3 mg/ml Konzentrat zur Herstellung einer InfusionslösungPAMIDRO-cell 3 mg/ml Konzentrat zur HerstellPAMIDRO-cell 3 mg/ml Konzentrat zur Herstellung einer InfusionslösungPamidronate Disodium Hospira 3 mg/ml inf. soPamidronate Disodium Hospira 3 mg/ml inf. sol. (conc.) i.v. vial 10 mltoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
DEPAMIDRO-cell 3 mg/ml Konzentrat zur Herstellung einer InfusionslösungSTADAPHARM GmbH11 Dec 202531 Dec 2026Manufacturing problem
Probleme in der Herstellung
DEPAMIDRO-cell 3 mg/ml Konzentrat zur Herstellung einer InfusionslösungSTADAPHARM GmbH11 Dec 202531 Dec 2026Manufacturing problem
Probleme in der Herstellung
DEPAMIDRO-cell 3 mg/ml Konzentrat zur Herstellung einer InfusionslösungSTADAPHARM GmbH11 Dec 202531 Dec 2026Manufacturing problem
Probleme in der Herstellung
DEPAMIDRO-cell 3 mg/ml Konzentrat zur Herstellung einer InfusionslösungSTADAPHARM GmbH11 Dec 202531 Dec 2026Manufacturing problem
Probleme in der Herstellung
DEPAMIDRO-cell 3 mg/ml Konzentrat zur Herstellung einer InfusionslösungSTADAPHARM GmbH11 Dec 202531 Dec 2026Manufacturing problem
Probleme in der Herstellung
DEPAMIDRO-cell 3 mg/ml Konzentrat zur Herstellung einer InfusionslösungSTADAPHARM GmbH11 Dec 202531 Dec 2026Manufacturing problem
Probleme in der Herstellung
BEPamidronate Disodium Hospira 3 mg/ml inf. sol. (conc.) i.v. vial 10 mlHospira Benelux6 Oct 202615 Jan 2027Increased demand

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Related medicines also in short supply

Alendronic Acid Clodronic Acid Ibandronic Acid Risedronic Acid Zoledronic Acid